Esha Singh*

Department of Maxillofacial Pathology and Microbiology, Raja Rajeswari Dental College and Hospital, Bengaluru, India

*Corresponding Author: Esha Singh, Department of Maxillofacial Pathology and Microbiology, Raja Rajeswari Dental College and Hospital, Bengaluru, India.

Received: October 26, 2021; Published: November 19, 2021

Since the first case of COVID-19 was reported in December 2019, there have been several additions to the already broad spectrum of its clinical manifestations. The SARS-CoV-2 being a respiratory virus has crucial significance in the otorhinolaryngologic specialty. ENT specific COVID symptoms range from minor cases of sore throat on the one hand to severe presentations of mucormycosis on the other hand. Mucormycosis is an atypical life threatening deep fungal infection with increased propensity of presentation in immunocompromised patients. COVID-19 being an immune-mediated disease has obvious implications in the pathogenesis of mucormycosis.

Citation

Citation: Esha Singh. “Rhino-orbital-cerebral Mucormycosis in COVID Scenario - A Pathologic Perspective". Acta Scientific Otolaryngology 3.12 (2021): 13-14.

Copyright

Copyright: © 2020 Esha Singh. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.